• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病聚集体中的脱氢氨基酸及其交联物。

Dehydroamino acids and their crosslinks in Alzheimer's disease aggregates.

作者信息

Markovich Samuel W, Frey Brian L, Scalf Mark, Shortreed Michael R, Smith Lloyd M

机构信息

Department of Chemistry, University of Wisconsin-Madison; Madison, WI 53706, USA.

出版信息

Brain Commun. 2025 Jan 16;7(1):fcaf019. doi: 10.1093/braincomms/fcaf019. eCollection 2025.

DOI:10.1093/braincomms/fcaf019
PMID:39882022
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11775630/
Abstract

Alzheimer's disease (AD) is characterized by the accumulation of protein aggregates, which are thought to be influenced by posttranslational modifications (PTMs). Dehydroamino acids (DHAAs) are rarely observed PTMs that contain an electrophilic alkene capable of forming protein-protein crosslinks, which may lead to protein aggregation. We report here the discovery of DHAAs in the protein aggregates from AD, constituting an unknown and previously unsuspected source of extensive proteomic complexity. We used mass spectrometry-based proteomics to discover 404 sites of DHAA formation in 171 proteins from protein aggregate-enriched human brain samples, 6-fold more sites than observed in the soluble protein fractions. The DHAA modifications are observed both directly and in the form of conjugates after reacting with abundant cellular nucleophiles or crosslinking to nucleophilic amino acid residues. We report 11 such crosslinks, including three in the Tau protein, which are 10-fold more abundant in AD samples compared with age-matched controls. Many of the proteins found to contain DHAAs and their conjugates are involved in protein aggregation or pathways dysregulated in AD. DHAAs are prevalent modifications in the AD brain proteome and give rise to protein crosslinks that may contribute to protein aggregation.

摘要

阿尔茨海默病(AD)的特征是蛋白质聚集体的积累,人们认为这受翻译后修饰(PTM)的影响。脱氢氨基酸(DHAA)是罕见的翻译后修饰,其包含能够形成蛋白质-蛋白质交联的亲电烯烃,这可能导致蛋白质聚集。我们在此报告了在AD患者的蛋白质聚集体中发现了DHAA,这构成了广泛蛋白质组复杂性的一个未知且先前未被怀疑的来源。我们使用基于质谱的蛋白质组学方法,在富含蛋白质聚集体的人脑样本中的171种蛋白质上发现了404个DHAA形成位点,比在可溶性蛋白质组分中观察到的位点多6倍。DHAA修饰既可以直接观察到,也可以在与丰富的细胞亲核试剂反应或与亲核氨基酸残基交联后以缀合物的形式观察到。我们报告了11种这样的交联,其中包括Tau蛋白中的三种,与年龄匹配的对照相比,这些交联在AD样本中的丰度高10倍。许多被发现含有DHAA及其缀合物的蛋白质都参与了AD中蛋白质聚集或失调的途径。DHAA是AD脑蛋白质组中普遍存在的修饰,并产生可能导致蛋白质聚集的蛋白质交联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a1e/11775630/77a790ad6795/fcaf019f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a1e/11775630/4fd1e7580192/fcaf019_ga.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a1e/11775630/3da9fc451ae1/fcaf019f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a1e/11775630/b4bca2a83b7f/fcaf019f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a1e/11775630/a2ffd3745760/fcaf019f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a1e/11775630/77a790ad6795/fcaf019f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a1e/11775630/4fd1e7580192/fcaf019_ga.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a1e/11775630/3da9fc451ae1/fcaf019f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a1e/11775630/b4bca2a83b7f/fcaf019f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a1e/11775630/a2ffd3745760/fcaf019f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a1e/11775630/77a790ad6795/fcaf019f4.jpg

相似文献

1
Dehydroamino acids and their crosslinks in Alzheimer's disease aggregates.阿尔茨海默病聚集体中的脱氢氨基酸及其交联物。
Brain Commun. 2025 Jan 16;7(1):fcaf019. doi: 10.1093/braincomms/fcaf019. eCollection 2025.
2
Quantitative proteomics of tau and Aβ in detergent fractions from Alzheimer's disease brains.阿尔茨海默病大脑去污剂组分中tau蛋白和Aβ的定量蛋白质组学
J Neurochem. 2023 Feb;164(4):529-552. doi: 10.1111/jnc.15713. Epub 2022 Nov 22.
3
Mass Spectrometry Analysis of Lysine Posttranslational Modifications of Tau Protein from Alzheimer's Disease Brain.阿尔茨海默病大脑中tau蛋白赖氨酸翻译后修饰的质谱分析
Methods Mol Biol. 2017;1523:161-177. doi: 10.1007/978-1-4939-6598-4_10.
4
Dehydroamino acid residues in bioactive natural products.生物活性天然产物中的去氢氨基酸残基。
Nat Prod Rep. 2024 Feb 21;41(2):273-297. doi: 10.1039/d3np00041a.
5
Quantitative Analysis of the Brain Ubiquitylome in Alzheimer's Disease.阿尔茨海默病大脑泛素组的定量分析。
Proteomics. 2018 Oct;18(20):e1800108. doi: 10.1002/pmic.201800108.
6
Dityrosine Cross-links are Present in Alzheimer's Disease-derived Tau Oligomers and Paired Helical Filaments (PHF) which Promotes the Stability of the PHF-core Tau (297-391) In Vitro.二酪氨酸交联存在于阿尔茨海默病来源的 Tau 寡聚体和双螺旋丝(PHF)中,这促进了 PHF-核心 Tau(297-391)在体外的稳定性。
J Mol Biol. 2022 Oct 15;434(19):167785. doi: 10.1016/j.jmb.2022.167785. Epub 2022 Aug 9.
7
Proteomic landscape of Alzheimer's Disease: novel insights into pathogenesis and biomarker discovery.阿尔茨海默病的蛋白质组学全景:发病机制和生物标志物发现的新见解。
Mol Neurodegener. 2021 Aug 12;16(1):55. doi: 10.1186/s13024-021-00474-z.
8
Phosphorylated tau interactome in the human Alzheimer's disease brain.人类阿尔茨海默病大脑中磷酸化 tau 的相互作用组。
Brain. 2020 Sep 1;143(9):2803-2817. doi: 10.1093/brain/awaa223.
9
Deep Profiling of the Aggregated Proteome in Alzheimer's Disease: From Pathology to Disease Mechanisms.阿尔茨海默病中聚集蛋白质组的深度剖析:从病理学到疾病机制
Proteomes. 2018 Nov 12;6(4):46. doi: 10.3390/proteomes6040046.
10
Dissecting Alzheimer's Disease Molecular Substrates by Proteomics and Discovery of Novel Post-translational Modifications.通过蛋白质组学解析阿尔茨海默病的分子基础及发现新的翻译后修饰。
OMICS. 2019 Jul;23(7):350-361. doi: 10.1089/omi.2019.0085. Epub 2019 Jun 21.

本文引用的文献

1
Myelin dysfunction drives amyloid-β deposition in models of Alzheimer's disease.髓鞘功能障碍导致阿尔茨海默病模型中的淀粉样β沉积。
Nature. 2023 Jun;618(7964):349-357. doi: 10.1038/s41586-023-06120-6. Epub 2023 May 31.
2
Bioinformatic analysis of the SPs and NFTs proteomes unravel putative biomarker candidates for Alzheimer's disease.对淀粉样前体蛋白(SPs)和神经纤维缠结(NFTs)蛋白质组进行生物信息学分析,揭示了阿尔茨海默病可能的生物标志物候选物。
Proteomics. 2023 Aug;23(15):e2200515. doi: 10.1002/pmic.202200515. Epub 2023 May 1.
3
Myelin in Alzheimer's disease: culprit or bystander?
阿尔茨海默病中的髓鞘:罪魁祸首还是旁观者?
Acta Neuropathol Commun. 2023 Mar 31;11(1):56. doi: 10.1186/s40478-023-01554-5.
4
Defective proteostasis in Alzheimer's disease.阿尔茨海默病中蛋白质稳态的缺陷。
Ageing Res Rev. 2023 Mar;85:101862. doi: 10.1016/j.arr.2023.101862. Epub 2023 Jan 21.
5
Discovery of Dehydroamino Acid Residues in the Capsid and Matrix Structural Proteins of HIV-1.发现 HIV-1 衣壳和基质结构蛋白中的去氢氨基酸残基。
J Proteome Res. 2022 Apr 1;21(4):993-1001. doi: 10.1021/acs.jproteome.1c00867. Epub 2022 Feb 22.
6
Challenges and hopes for Alzheimer's disease.阿尔茨海默病的挑战与希望。
Drug Discov Today. 2022 Apr;27(4):1027-1043. doi: 10.1016/j.drudis.2022.01.016. Epub 2022 Feb 1.
7
The probabilistic model of Alzheimer disease: the amyloid hypothesis revised.阿尔茨海默病的概率模型:淀粉样蛋白假说的修正。
Nat Rev Neurosci. 2022 Jan;23(1):53-66. doi: 10.1038/s41583-021-00533-w. Epub 2021 Nov 23.
8
Dehydroamino acid chemical biology: an example of functional group interconversion on proteins.脱氢氨基酸化学生物学:蛋白质上官能团相互转化的一个例子。
RSC Chem Biol. 2020 Nov 6;1(5):298-304. doi: 10.1039/d0cb00174k. eCollection 2020 Dec 1.
9
Extracellular GAPDH Promotes Alzheimer Disease Progression by Enhancing Amyloid-β Aggregation and Cytotoxicity.细胞外甘油醛-3-磷酸脱氢酶通过增强淀粉样β蛋白聚集和细胞毒性促进阿尔茨海默病进展。
Aging Dis. 2021 Aug 1;12(5):1223-1237. doi: 10.14336/AD.2020.1230. eCollection 2021 Aug.
10
LanCLs add glutathione to dehydroamino acids generated at phosphorylated sites in the proteome.LanCLs 将谷胱甘肽添加到蛋白质组中磷酸化位点产生的去氢氨基酸中。
Cell. 2021 May 13;184(10):2680-2695.e26. doi: 10.1016/j.cell.2021.04.001. Epub 2021 Apr 30.